Literature DB >> 23228010

Design, synthesis, and antibacterial activities of conformationally constrained kanamycin A derivatives.

Wenxuan Zhang1, Ying Chen, Qingzhao Liang, Hui Li, Hongwei Jin, Liangren Zhang, Xiangbao Meng, Zhongjun Li.   

Abstract

A series of conformationally constrained kanamycin A derivatives with a 2'-hydroxyl group in ring I and a 5-hydroxyl group in ring II tethered by carbon chains were designed and synthesized. Pivotal 5,2'-hydroxyl groups were exposed, and the kanamycin A intermediate was synthesized from 5, 2', 4″, 6″-di-O-benzylidene-protected tetraazidokanamycin A. Cyclic kanamycin A derivatives with intramolecular 8-, 9-, 10-, and 11-membered ethers were then prepared by cesium carbonate mediated Williamson ether synthesis or a ring-closing metathesis reaction. The kanamycin A derivatives were assayed against both susceptible and resistant bacterial strains. Although no derivative showed better antibacterial activities than kanamycin A, the antibacterial activities of these cyclic kanamycin A derivatives indeed varied with the length of the bridge. Moreover, different variations of activities were observed between the susceptible and resistant bacterial strains. More tightly constrained derivative 2 with a one-carbon bridge showed better activity than the others against susceptible strains, but it was much less effective for resistant bacterial strains than derivative 3 with a two-carbon bridge and derivative 6 with an unsaturated four-carbon bridge.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228010     DOI: 10.1021/jo302247x

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  6 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Tobramycin Variants with Enhanced Ribosome-Targeting Activity.

Authors:  Marina Y Fosso; Hongkun Zhu; Keith D Green; Sylvie Garneau-Tsodikova; Kurt Fredrick
Journal:  Chembiochem       Date:  2015-06-17       Impact factor: 3.164

3.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

Review 4.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

5.  Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Microb Drug Resist       Date:  2017-12-20       Impact factor: 3.431

6.  Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria.

Authors:  Richard J Fair; Lisa S McCoy; Mary E Hensler; Bernice Aguilar; Victor Nizet; Yitzhak Tor
Journal:  ChemMedChem       Date:  2014-07-23       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.